<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011133'>Increased sensitivity to ionizing radiation</z:hpo> has been shown to be due to defects in double-strand break repair and mutations in the proteins that detect DNA damage </plain></SENT>
<SENT sid="1" pm="."><plain>However, it is now recognized that the cellular radiation response is complex and that radioresistance/radiosensitivity may also be regulated at different levels in the radiation signal transduction pathway </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we describe a direct relationship between resistance to radiation-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and defective <z:chebi fb="7" ids="17761">ceramide</z:chebi> signaling </plain></SENT>
<SENT sid="3" pm="."><plain>Radiation sensitivity in human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells correlated with the immediate accumulation of the second messenger <z:chebi fb="7" ids="17761">ceramide</z:chebi> </plain></SENT>
<SENT sid="4" pm="."><plain>In the BL30A Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> line, <z:chebi fb="7" ids="17761">ceramide</z:chebi> increased 4-fold by 10 min postirradiation (10 Gy), and in the moderately sensitive <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">HL</z:e>-60 <z:hpo ids='HP_0001909'>leukemia</z:hpo> cells, <z:chebi fb="7" ids="17761">ceramide</z:chebi> accumulated 2.5-fold above basal levels </plain></SENT>
<SENT sid="5" pm="."><plain>In contrast, in <z:hpo ids='HP_0000001'>all</z:hpo> radioresistant <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells examined, including several Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> lines (BL30K, BL29, and BL36) and the MO59K <z:hpo ids='HP_0009733'>glioma</z:hpo> cell line, <z:chebi fb="7" ids="17761">ceramide</z:chebi> did not accumulate postirradiation </plain></SENT>
<SENT sid="6" pm="."><plain>The ability to abrogate <z:chebi fb="7" ids="17761">ceramide</z:chebi> production by pretreatment with the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> promoter, 12-O-tetradecanoylphorbol 13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi>, conferred resistance to radiation-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the sensitive BL30A cells </plain></SENT>
<SENT sid="7" pm="."><plain>An isogenic subline of BL30A, BL30K, was resistant to both C8-<z:chebi fb="7" ids="17761">ceramide</z:chebi> (20 microM) and ionizing radiation-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="8" pm="."><plain>Bypassing the block in radiation-induced <z:chebi fb="7" ids="17761">ceramide</z:chebi> production by the addition of exogenous <z:chebi fb="7" ids="17761">ceramide</z:chebi> was not sufficient to induce <z:mpath ids='MPATH_3'>apoptosis</z:mpath>; this suggests the existence of a second <z:chebi fb="7" ids="17761">ceramide</z:chebi>-associated signaling defect in these radioresistant cells that confers resistance to <z:chebi fb="7" ids="17761">ceramide</z:chebi>-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="9" pm="."><plain>Thus, these results provide compelling evidence that <z:chebi fb="7" ids="17761">ceramide</z:chebi> is an essential mediator of radiation-induced <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and that defective <z:chebi fb="7" ids="17761">ceramide</z:chebi> signaling confers an <z:mpath ids='MPATH_3'>apoptosis</z:mpath>-resistant phenotype in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
</text></document>